Blackthorn Therapeutics

blackthorn therapeutics is a clinical-stage biopharmaceutical company dedicated to transforming the lives of people with neurobehavioral disorders through the discovery and development of novel, targeted treatments. blackthorn is building a robust pipeline of first- and best-in-class treatments, and is redefining the industry approach to drug discovery and development through its inform™ platform, which links brain physiology and its relationship to behavior. with its network of collaborations with leading academic investigators, blackthorn is developing and deploying a set of technologies that will enable focused, rapid, resource-efficient translational studies for drug development. the company is headquartered in south san francisco, california. for more information, please visit www.blackthornrx.com